Hepatocyte growth factor gene therapy for hypertension.

8Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Hepatocyte growth factor (HGF) has mitogenic, motogenic, and morphogenic biological activities as well as helps in regenerating various tissues. In cardiovascular organs, HGF was reported to have anti-apoptotic, anti-fibrotic, and vasodilating effects. HGF has close relationships with hypertension, arteriosclerosis, and heart failure. HGF enhances renal regeneration and suppresses the progression of hypertension. Intramuscular electroporation of the therapeutic gene is a simple, economic, and low toxic method compared with systemic administration of the purified proteins or peptides. We outline the technique of intramuscular electroporation of HGF gene as a remedy for hypertension.

Cite

CITATION STYLE

APA

Komamura, K., Miyazaki, J. I., Imai, E., Matsumoto, K., Nakamura, T., & Hori, M. (2008). Hepatocyte growth factor gene therapy for hypertension. Methods in Molecular Biology (Clifton, N.J.), 423, 393–404. https://doi.org/10.1007/978-1-59745-194-9_31

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free